Literature DB >> 3198943

In vivo killing of intracellular visceral Leishmania donovani by a macrophage-targeted hydrogen peroxide-generating system.

H W Murray1, C F Nathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3198943     DOI： 10.1093/infdis/158.6.1372

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Ascorbate peroxidase from Leishmania major controls the virulence of infective stage of promastigotes by regulating oxidative stress.

Authors:  Swati Pal; Subhankar Dolai; Rajesh K Yadav; Subrata Adak
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

2.  Use of antimony in the treatment of leishmaniasis: current status and future directions.

Authors:  Arun Kumar Haldar; Pradip Sen; Syamal Roy
Journal:  Mol Biol Int       Date:  2011-06-08

3.  Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice.

Authors:  Suraj P Parihar; Mary-Anne Hartley; Ramona Hurdayal; Reto Guler; Frank Brombacher
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

4.  Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony.

Authors:  Douglas S Moreira; Rubens L Monte Neto; Juvana M Andrade; Ana Maria M Santi; Priscila G Reis; Frédéric Frézard; Silvane M F Murta
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-09-05       Impact factor: 4.077
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.